Photodynamic Therapy Derived Personalized Whole Cell Tumor Vaccine Prevents Postsurgery Tumor Recurrence and Metastasis
Small · 2024
DOI: 10.1002/smll.202308456 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Chunyu Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Materia…. Hauptthemen laut MEDLINE: Photochemotherapy, Cancer Vaccines, Neoplasm Metastasis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing National Laboratory for Molecular Sciences, Research Funds on Biomedical Translation of China-Japan Friendship Hospital.
Abstract (Originalsprache)
In order to avoid the time‐consuming and laborious identification of tumor‐specific antigens (TSAs) during the traditional vaccine fabrication process, a versatile photodynamic therapy (PDT)‐based method is developed to construct a whole‐tumor antigen tumor vaccine (TV) from surgically resected tumor tissues for personalized immunotherapy. Mucoadhesive nanoparticles containing small‐molecular photosensitizer are fabricated and directly co‐incubated with suspended tumor cells obtained after cytoreduction surgery. After irradiation with a 405 nm laser, potent immunogenic cell death of cancer cells could be induced. Along with the release of TSAs, the as‐prepared TV could activate safe and robust tumor‐specific immune responses, leading to efficient suppression of postsurgery tumor recurrence and metastasis. The as‐prepared TV cannot only be applied alone through various administration routes but also synergize with immunoadjuvant, chemotherapeutics, and immune checkpoint blockers to exert more potent immune responses. This work provides an alternative way to promote the clinical translation of PDT, which is generally restricted by the limited penetration of light. Moreover, the versatile strategy of vaccine fabrication also facilitates the clinical application of personalized whole‐cell tumor vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Materials Science and Engineering, Beijing University of Chemical Technology,…
- The State Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China.
- Beijing National Laboratory for Molecular Sciences, Beijing, 100190, China.
ORCID-Profile: Qingsong Yu
Förderung
- National Natural Science Foundation of China
- Beijing National Laboratory for Molecular Sciences
- Research Funds on Biomedical Translation of China-Japan Friendship Hospital
- Fundamental Research Funds for the Central Universities of Beijing University of Chemical Technology
Zitieren
APA
Yang, C., Jiang, Y., Zhang, K., Zhu, X., Li, J., Yu, H., Chen, J., Gu, X., Gan, Z., & Yu, Q. (2024). Photodynamic Therapy Derived Personalized Whole Cell Tumor Vaccine Prevents Postsurgery Tumor Recurrence and Metastasis. Small. https://doi.org/10.1002/smll.202308456
Vancouver
Yang C, Jiang Y, Zhang K, Zhu X, Li J, Yu H, et al. Photodynamic Therapy Derived Personalized Whole Cell Tumor Vaccine Prevents Postsurgery Tumor Recurrence and Metastasis. Small. 2024. doi:10.1002/smll.202308456
BibTeX
@article{Yang2024,
author = {Yang, Chunyu and Jiang, Yitong and Zhang, Kaixin and Zhu, Xianqi and Li, Jianlin and Yu, Haiwang and Chen, Jiawei and Gu, Xinggui and Gan, Zhihua and Yu, Qingsong},
title = {Photodynamic Therapy Derived Personalized Whole Cell Tumor Vaccine Prevents Postsurgery Tumor Recurrence and Metastasis},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202308456}
}
EUVIMED